Commitment and Contingencies (Details) |
Dec. 16, 2011
USD ($)
$ / shares
shares
|
---|---|
Employment Agreement Details | |
Annual base salary | $ | $ 240,000 |
Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation | 2.00% |
Exercise price per share warrants entitled | $ / shares | $ 0.25 |
Warrant for shares upon identification of bio-active agents | 500,000 |
Warrant for shares to be issued upon upon entering into a business contract | 500,000 |
Receives in cash payments | $ | $ 500,000 |
Warrant for shares upon the Company entering into a co-development agreement | 1,000,000 |
Partner provides atleast in cash or in-kind outlays | $ | $ 2,000,000 |
Warrant for shares upon the Company entering into a co-development agreement | 1,000,000 |
Warrant for shares upon upon the Company entering into a pharmaceutical development agreement | 1,000,000 |
X | ||||||||||
- Definition Annual base salary No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Exercise price per share warrants entitled No definition available.
|
X | ||||||||||
- Definition Partner provides atleast in cash or in-kind outlays No definition available.
|
X | ||||||||||
- Definition Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation No definition available.
|
X | ||||||||||
- Definition The Company receives in cash payments under the business contract. No definition available.
|
X | ||||||||||
- Definition Warrant for shares to be issued upon upon entering into a business contract No definition available.
|
X | ||||||||||
- Definition Warrant for shares upon identification of bio-active agents No definition available.
|
X | ||||||||||
- Definition Warrant for shares upon the Company entering into a co-development agreement No definition available.
|
X | ||||||||||
- Definition Warrant for shares upon the Company entering into a co-development agreement No definition available.
|
X | ||||||||||
- Definition Warrant for shares upon upon the Company entering into a pharmaceutical development agreement No definition available.
|